Reuters logo
BRIEF-JDRF, VTV Therapeutics collaborate on Phase 2 study of novel treatment for type 1 diabetes
September 6, 2017 / 11:18 AM / 3 months ago

BRIEF-JDRF, VTV Therapeutics collaborate on Phase 2 study of novel treatment for type 1 diabetes

Sept 6 (Reuters) - VTV Therapeutics Inc

* JDRF and VTV Therapeutics announce collaboration on Phase 2 study of novel treatment for Type 1 diabetes

* VTV Therapeutics Inc - JDRF has committed $3 million to study, and VTV will contribute an equal amount

* VTV Therapeutics - study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy for people with T1D Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below